Comparison of plasma to tissue DNA mutations in surgical patients with non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 154, Issue 3, 2017, Pages 1123-1131.e2

  Chen, Kezhong ^a   Zhang, Jingbo ^b   Guan, Tian ^a   Yang, Fan ^a   Lou, Feng ^b   Chen, Wei ^b   Zhao, Mingyu ^b   Zhang, Jay ^b   Chen, Siyi ^c   Wang, Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b San Valley Biotechnology Incorporated   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

circulating tumor DNA; lung cancer; surgery

Indexed keywords

CIRCULATING TUMOR DNA; DNA; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUTATION RATE; NEXT GENERATION SEQUENCING; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEGMENTECTOMY; SOMATIC MUTATION; SQUAMOUS CELL LUNG CARCINOMA; SURGICAL PATIENT; TISSUE LEVEL; WEDGE RESECTION; DNA MUTATIONAL ANALYSIS; FEASIBILITY STUDY; GENETICS; HIGH THROUGHPUT SEQUENCING; LUNG TUMOR; PATHOLOGY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

CARCINOMA, NON-SMALL-CELL LUNG; CIRCULATING TUMOR DNA; DNA MUTATIONAL ANALYSIS; FEASIBILITY STUDIES; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; THORACIC SURGERY, VIDEO-ASSISTED;

EID: 85020763137     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2017.04.073     Document Type: Article

References (30)

1. Bettegowda, C., Sausen, M., Leary, R.J., Kinde, I., Wang, Y., et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med, 6, 2014, 224ra224.
2. Lim, E., Tay, A., Von Der Thusen, J., Freidin, M.B., Anikin, V., Nicholson, A.G., et al. Clinical results of microfluidic antibody-independent peripheral blood circulating tumor cell capture for the diagnosis of lung cancer. J Thorac Cardiovasc Surg 147 (2014), 1936–1938.
3. Heitzer, E., Ulz, P., Geigl, J.B., Circulating tumor DNA as a liquid biopsy for cancer. Clin Chem 61 (2015), 112–123.
4. Newman, A.M., Bratman, S.V., To, J., Wynne, J.F., Eclov, N.C., Modlin, L.A., et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med 20 (2014), 548–554.
5. Narayan, A., Carriero, N.J., Gettinger, S.N., Kluytenaar, J., Kozak, K.R., Yock, T.I., et al. Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res 72 (2012), 3492–3498.
6. Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R.J., et al. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci Transl Med, 7, 2015, 302ra133.
7. Bai, X., Zhang, E., Ye, H., Nandakumar, V., Wang, Z., Chen, L., et al. PIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing. PLoS One, 9, 2014, e99306.
8. Xu, S., Lou, F., Wu, Y., Sun, D.Q., Zhang, J.B., Chen, W., et al. Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients. Cancer Lett 370 (2016), 324–331.
9. Gould, M.K., Donington, J., Lynch, W.R., Mazzone, P.J., Midthun, D.E., Naidich, D.P., et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143 (2013), e93S–120S.
10. Swensen, S.J., Silverstein, M.D., Edell, E.S., Trastek, V.F., Aughenbaugh, G.L., Ilstrup, D.M., et al. Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc 74 (1999), 319–329.
11. Li, Y., Chen, K.Z., Wang, J., Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people. Clin Lung Cancer 12 (2011), 313–319.
12. An, S.J., Chen, Z.H., Su, J., Zhang, X.C., Yang, J.J., Zhou, Q., et al. Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status. PLoS One, 7, 2012, e40109.
13. Shi, Y., Au, J.S., Thongprasert, S., Srinivasan, S., Tsai, C.M., Khoa, M.T., et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol 9 (2014), 154–162.
14. Mok, T., Wu, Y.L., Lee, J.S., Yu, C.J., Sriuranpong, V., Sandoval-Tan, J., et al. Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC patients treated with first-line intercalated erlotinib and chemotherapy. Clin Cancer Res 21 (2015), 3196–3203.
15. Rosell, R., Karachaliou, N., Lung cancer: Using ctDNA to track EGFR and KRAS mutations in advanced-stage disease. Nat Rev Clin Oncol 13 (2016), 401–402.
16. Guo, K., Zhang, Z., Han, L., Han, J., Wang, J., Zhou, Y., et al. Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer. Onco Targets Ther 8 (2015), 3289–3296.
17. Jamal-Hanjani, M., Wilson, G.A., Horswell, S., Mitter, R., Sakarya, O., et al. Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer. Ann Oncol 27 (2016), 862–867.
18. Gerlinger, M., Rowan, A.J., Horswell, S., Larkin, J., Endesfelder, D., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366 (2012), 883–892.
19. Swanton, C., Intratumor heterogeneity: evolution through space and time. Cancer Res 72 (2012), 4875–4882.
20. Naidich, D.P., Bankier, A.A., MacMahon, H., Schaefer-Prokop, C.M., Pistolesi, M., Goo, J.M., et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 266 (2013), 304–317.
21. Izumchenko, E., Chang, X., Brait, M., Fertig, E., Kagohara, L.T., Bedi, A., et al. Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA. Nat Commun, 6, 2015, 8258.
22. Zhai, H., Zhong, W., Yang, X., Wu, Y.L., Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer. Transl Lung Cancer Res 4 (2015), 82–93.
23. de Bruin, E.C., McGranahan, N., Mitter, R., Salm, M., Wedge, D.C., Yates, L., et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346 (2014), 251–256.
24. Schaake, E.E., Kappers, I., Codrington, H.E., Valdes, R.A., Teertstra, H.J., et al. Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer. J Clin Oncol 30 (2012), 2731–2738.
25. Lara-Guerra, H., Waddell, T.K., Salvarrey, M.A., Joshua, A.M., Chung, C.T., Paul, N., et al. Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer. J Clin Oncol 27 (2009), 6229–6236.
26. Murtaza, M., Dawson, S.J., Pogrebniak, K., Rueda, O.M., Provenzano, E., Grant, J., et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun, 6, 2015, 8760.
27. Diehl, F., Schmidt, K., Choti, M.A., Romans, K., Goodman, S., Li, M., et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 14 (2008), 985–990.
28. Reddy, R.M., Murlidhar, V., Zhao, L., Grabauskiene, S., Zhang, Z., Ramnath, N., et al. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer. J Thorac Cardiovasc Surg 151 (2016), 852–857.
29. Ma, S., Shen, L., Qian, N., Chen, K., The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. Cancer Biomark 10 (2011), 155–162.
30. Wan, J.C., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J.D., Caldas, C., et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer 17 (2017), 223–238.